Enhancing AAV Manufacturing Yield Via Mini-Helper Plasmid

Navigating AI Compliance In Life Sciences: FDA Policy Insights For AI Governance

When High-Stakes ADC Decisions Can't Wait for More Material or Better Data

Modular VFlexible Aseptic Filling Lines

Reducing Particulate-Related Batch Risk In Bioprocessing

Residual DNA Testing Across Biotherapeutics

Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity

Building Scalable Non-Viral Gene-Edited Cell Therapy Processes

Automating Cell Therapy Manufacturing Without Redesigning Workflows

How Intensified Upstream Processing Improves Scale-Up And Tech Transfer

Generate Stable High-Producing Clones In 14 Weeks

Reducing Particulate-Related Batch Risk In Bioprocessing

How Intensified Upstream Processing Improves Scale-Up And Tech Transfer

Generate Stable High-Producing Clones In 14 Weeks

Using Residual DNA Quantification Data To De-Risk mAb Development

Efficient mAb Development With A Flexible Purification Toolkit

CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic

Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview

How MacroGenics Increased mAb Titers By Up To 80% In Scale-Up

Boost CHO Cell Protein Production By Up To 146% With Efficient-Pro™ Feed Solutions

Driven By Performance: Empowering Biotech Innovation From Lab To Life

Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter

DynaDrive S.U.B. Video Series

How To Use 5 And 10L BPCs Of The CTS Optmizer Family Of Serum Free Media

Go Beyond Custom Media Screening And Prototyping

Nanoassemblr Blaze mRNA Vaccine Demo

How MacroGenics Increased mAb Titers By Up To 80% In Scale-Up

OsmoTECH® HT Automated Micro-Osmometer

HyPerforma 5:1 Single-Use Bioreactor (S.U.B.) Setup And Installation Part 3

Enabling Assurance Of Supply Through Evolving Bioprocessing Needs

Advances In Custom Medium Development: The Multi-Omics Difference

Inside Bioprocessing: Multi-Omics

Perfusion: Planning A Run

Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview

Aegis Film For DynaDrive Single-Use Bioreactors

How To Use 5 And 10L BPCs Of The CTS Optmizer Family Of Serum Free Media

Nunc Standard Closed Cell Factory System

Supporting Cells To Overcome Shear Forces

How To Use Mobius® Single-Use Assembly For High Cell Density Cryopreservation

Mycap® Bottle Closures – Aseptic Fluid Transfer Systems For Bottles

How To Fill And Empty Nunc Standard Cell Factory System

Multi-Specific Antibody Development: What Challenges The Need For Speed?

Optimize Your Cell Culture Feed Strategy With Cellvento® ModiFeed Prime COMP

Cell Therapy Bioprocessing Workflow Cinematic

Mycap® CCX Cell Culture Expansion System

How To Fill And Empty Nunc Standard Closed Cell Factory System

MilliporeSigma Large Scale Capabilities Tour

A Collaboration With Zurich University Of Applied Sciences

Nunc Standard Closed Cell Factory System

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Integrated Technologies And Glycosylation Tuning In Upstream Bioprocessing

A Faster, More Sensitive Approach To Virus Detection

How To Fill And Empty Nunc Standard Cell Factory System

A Next-Generation CHO Host For High Producing Clones

Can Kinetics Provide Detailed Information About Binding Interactions?

Is The Sensitivity Of Optical Biosensors Important?

Cytovance Customer Testimonial: Thermo Scientific Single-Use Technologies

Optimize Your Cell Culture Feed Strategy With Cellvento® ModiFeed Prime COMP

The CHO Toolkit: Flexible Solutions For Complex Molecules

Agile Cell Processing Using Continuous Counterflow Centrifugation

Feed Media Can Significantly Impact Process Performance

A Closer Look At The Spin Filter

A Flexible Solution To Automate Concentration, Washing, And Formulation

Pall Stax™ mAx Platform For mAbs Clarification

A Closed And Automated Solution To Streamline Your Workflow

Laboratory Filtration Products For Clone Selection, Optimization And Recombinant Protein Analysis

High-Viability Cell Processing, Simplified

Harvesting In The PBS Mini

CTS DynaCellect Fluidics Demonstration

Where Does Upstream End And Downstream Begin?

Advantages of Vertical-Wheel Bioreactors For High-Yield PSC Expansion

How To Use The CTS DynaCellect Bead Removal Kit

A Collaboration With Zurich University Of Applied Sciences

Go Beyond Custom Media Screening And Prototyping

Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

Supporting Cells To Overcome Shear Forces

How MacroGenics Increased mAb Titers By Up To 80% In Scale-Up

Enabling Assurance Of Supply Through Evolving Bioprocessing Needs

Why PAT Is Foundational To Continuous Manufacturing & What Stands In The Way

Advances In Custom Medium Development: The Multi-Omics Difference

Inside Bioprocessing: Multi-Omics

Perfusion: Planning A Run

Applications For PAT And Continuous: Seed Trains & Data Anomalies

Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.

Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.

BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin

BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D.

Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.

Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho

Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.

The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry

Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.

Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane

Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.

Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.

In Biosimilar Analytical Development, Is A CQA Ever Not Critical?

Standards' Role In Biosimilarity Assessment

The Burden Of Proof Has Shifted To Analytics For Biosimilar Approval

The Necessity Of Potency Assay Matrices For Complex Proteins

In The U.S., Pharmacy-Level Biosimilar Substitution Remains A High Bar

How To Avoid A Biosimilar Comparative Efficacy Study, If Possible

Building A Comprehensive Control Strategy For Biosimilar Analytics

Comparing Biosimilars To Drifting Reference Product Data

Criticism Of FDA's Limited Proof-Of-Principle Ignores The Full Breadth Of Biosimilar CQA Understanding

Levers For Streamlining And Optimizing The Biosimilar Process

Platforming And The Future Of Standardized Manufacturing Chassis

Protecting Biopharma Manufacturing Supply Chains

Building Resilience In Biomanufacturing Operations

How Will U.S. Tariffs And The BIOSECURE Act Impact Global Biopharma Markets?

AES Clean Technology Career Opportunities

Litebeam LED Cleanroom Lighting

A Contamination-Reducing Solution In Aseptic Transfer

Time And Cost Savings Of Modular Cleanrooms Vs. Stick Built Cleanrooms

Key Factors When Selecting A Modular Cleanroom For Drug Manufacturing

Modular Facilities - The Proven Response For Rapid Biomanufacturing Anywhere

Setup Made Simple With The BioTitan Retention Device

Cleanroom Design Cost Control

Bioprocessing Equipment And Automation Product Portfolio Overview

Making Data Work

Cleanroom Manufacturer Expands Capacity To Meet Industry Needs

Flexible Manufacturing: Better, Faster Virus Production

Life Changing Products: Modernizing Regulated Product Development And Manufacturing

Building A Defensible Visual Inspection Program With Purpose-Built Software

Inline Buffer Formulation Systems

Large-Scale Lentivirus Manufacturing With A Transfection Complex Stabilizer

Modifying Elution Conditions For Enhanced Impurity Removal

Trusted Performance With A Plus: Seamless Transfer From R&D To Commercial

Optimize Every Step In Your Biopharma Site

Streamline Fluid Disconnections And Reduce Tear-Down Complexity

Advanced Adherent Corning Platforms For Scalable Viral Vaccine Manufacturing

Digital Logbooks Improve Data Integrity And Audit Readiness

From Data Promises To Factory Results: Reality Leadership In Pharma

The Importance Of Having A Strong Reject Characterization Program

Why PAT Is Foundational To Continuous Manufacturing & What Stands In The Way

Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview

Applications For PAT And Continuous: Seed Trains & Data Anomalies

How Industry Orgs, Associations Are Supporting Continuous Manufacturing

Who's Ready For Continuous Manufacturing?

A CDMO Perspective: Bioprocess Automation And Data Management

How Do We Quantify Continuous Manufacturing Benefits?

Sensors & Data: What Feeds Effective Continuous Manufacturing?

Q&A On Continuous Manufacturing In Biopharma

Methods To Process Intensification, Downstream Challenges In Continuous Manufacturing

Can Continuous Biomanufacturing Borrow From Small Molecules?

OsmoTECH XT Single-Sample Micro-Osmometer Demo

Pragmatic Computational Biology with Andrew Satz

Cell And Gene Therapy Innovations

AI/ML As Tools In Biomanufacturing

Boost Scalability And Efficiency With Automated Filtration

Explore The Analytics Knowledge Hub

A Robust, Future-Ready Solution That Adapts To Your Needs

Real-Time Monitoring And Automated Sampling For Enhanced Efficiency

Multi-Specific Antibody Development: What Challenges The Need For Speed?

A Straightforward Path Toward Regulatory Compliance & Data Integrity With Your Microbial Testing Systems

A CDMO Perspective: Bioprocess Automation And Data Management

PAT In Multi-Specific Antibody Manufacturing

GLP And The Impact To Start Up Companies

Pragmatic Computational Biology with Andrew Satz

Validation Of An LCMS Hybrid Assay With EVOSEP Cleanup

Nanoassemblr Blaze mRNA Vaccine Demo

Saudi Arabia Government Leaders Discuss Agile Manufacturing Beyond Borders

RNA Delivery Business with Liberate's Shawn Davis, Ph.D. & Walter Strapps, Ph.D.

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

LC/MS/MS Analysis Of Coproporphyrin 1, Coproporphyrin 3 In Human Plasma

Development Of A Mitra Tip Extraction Assay Coupled With LC-MSMS

ResDNASEQ Workflow Solution

The NanoAssemblr® Spark™ Instrument Demo

Addressing Manufacturability And Scalability Challenges In Multispecifics Purification

Go Beyond Custom Media Screening And Prototyping

Nanoassemblr Blaze mRNA Vaccine Demo

AI/ML As Tools In Biomanufacturing

Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

OsmoTECH® HT Automated Micro-Osmometer

Accelerating Novel Cell Therapies To Market

Advances In Custom Medium Development: The Multi-Omics Difference

Boost Scalability And Efficiency With Automated Filtration

Driving Efficiency Through Process Intensification

Inside Bioprocessing: Multi-Omics

Perfusion: Planning A Run

The Risk And Reality Of 3D Printed Parts In Single-Use Workflows

The Levers And Tradeoffs That Drive Process Productivity

Downstream Decisions To Maximize Viral Vector Yields And Reduce COGs

Closing The Adoption Gap For Advanced Single-Use Materials

Process Control's Increasing Role In Biosimilar Approval

Optimizing Process Development Through Upstream And Downstream Integration

Protecting Bioprocessing Operations And Supply Chains In A Turbulent Economy

How Digital Tools Are Accelerating Biopharma Development

Evolving CMC Strategies To Enable Next-Gen ADCs

Aligning CMC And MSAT To Move PATs Out Of Pilot Mode

Single-Use Harmonization Needs A Tune Up

Challenges And Considerations For Purifying Multispecific Molecules

Discovering A Unique Multimillion Euro Nanotechnology Facility

How Will U.S. Tariffs And The BIOSECURE Act Impact Global Biopharma Markets?

Explore The M Lab Collaboration Center In Burlington MA

MilliporeSigma Capacity Update October 2025: ADC

Building Resilience In Biomanufacturing Operations

M Lab™ Collaboration Centers Video

Collaboration & Expertise, The Keys To Efficiency And Scalability Across All Modalities

The Journey To Safety Through Viral Clearance

Increasing The Reach Of Cell And Gene Therapies

ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients

Raman PAT Platform – Model Building Support Animation

Thermo Fisher Scientific China Single-Use Technologies Capacity Expansion

Flexibility First: A Fill And Finish Collaboration Story

Fill And Finish: Your Final Step Is Our First Priority

Enhancing Aseptic Fill-Finish Processes

BioTitan Retention Device Overview

Maximize Your Drug Product Recovery With A Complete Fill Finish Solution

Maintaining Downstream Quality In Multi-Specific Antibody Manufacturing

Multi-Specific Antibody Development: What Challenges The Need For Speed?

Single-Use Filter Transfer Sets Ready For Final Filling

Mycap® Bottle Closures – Aseptic Fluid Transfer Systems For Bottles

Isolator Fill-Finish Process With Single-Use (SU) Systems

Nanoassemblr Blaze mRNA Vaccine Demo

Nanoassemblr Ignite mRNA Vaccine Demo

How To Select Your DSP Chromatography Technology

Addressing Manufacturability And Scalability Challenges In Multispecifics Purification

Chromatography Resins And Continuous Bioprocessing

High Capacity, Scalable Cation Exchange Chromatography Membrane For Purification Of Monoclonal Antibody

Robust Workflow For Single Cell Cloning Of iPSCs For Making cGMP Master Cell Banks

What Is The DynaChrom™ Single-Use Chromatography System?

Boost Scalability And Efficiency With Automated Filtration

Intensified Virus Purification: Better, Faster, Virus Production

Expanding Manufacturing Of Purification Resins To Align With Customer Demands

Solutions For Diverse Biomolecule Purification

CaptureSelect™ Technology - Powerful Affinity For More Streamlined Purification

Concentrate Your Product After One Path With Pellicon® Single Pass Tangential Flow Filtration

What Is Mixed-Mode Chromatography?

Redefine Your Oligonucleotide Manufacturing

Biopharma Supply, Reimagined: Blarney, A Climate-Neutral Facility For Best-In-Class Filters

Multi-Specific Antibody Development: What Challenges The Need For Speed?

Pellicon® Capsule: How Is It Made And How Does It Work?

Optimized Purity Of A Monoclonal Antibody, Carsten Voß Video

Maintaining Downstream Quality In Multi-Specific Antibody Manufacturing

The Blazar® Platform In A Minute

Strategies For Viral Inactivation And Filtration In Multispecifics

Purification Strategies For New Classes Of Antibodies

Targeting The Fast Lane With Optimized Viral Detection

Addressing Manufacturability And Scalability Challenges In Multispecifics Purification

Why Polar: A Day In The Life Of A Scientist

Why PAT Is Foundational To Continuous Manufacturing & What Stands In The Way

Introduction of New Automated Micro-Osmometer

Select Your Best Downstream Process Intensification Strategy

Applications For PAT And Continuous: Seed Trains & Data Anomalies

System To Simplify Single-Channel Pipette Calibration And User Training

How Industry Orgs, Associations Are Supporting Continuous Manufacturing

Increasing The Reach Of Cell And Gene Therapies

Fill And Finish: Your Final Step Is Our First Priority

Who's Ready For Continuous Manufacturing?

Flexibility First: A Fill And Finish Collaboration Story

Fill And Finish: Your Final Step Is Our First Priority

Simplifying Final Filling - Single-Use Transfer And Filling Solutions

Streamline Production With A Final Filling Single-Use Set

A Contamination-Reducing Solution In Aseptic Transfer

Enhancing Aseptic Fill-Finish Processes

BioTitan Retention Device Overview

Maximize Your Drug Product Recovery With A Complete Fill Finish Solution

Single-Use Filter Transfer Sets Ready For Final Filling

Mycap® Bottle Closures – Aseptic Fluid Transfer Systems For Bottles

Isolator Fill-Finish Process With Single-Use (SU) Systems

MilliporeSigma Large Scale Capabilities Tour

How Will U.S. Tariffs And The BIOSECURE Act Impact Global Biopharma Markets?

Singapore Single-Use Site Capacity Expansion

Saudi Arabia Government Leaders Discuss Agile Manufacturing Beyond Borders

Building Resilience In Biomanufacturing Operations

Enabling Assurance Of Supply Through Evolving Bioprocessing Needs

Thermo Fisher Scientific Single-Use Global Manufacturing Network

Bioprocessing Raw Material And Equipment Costs Are Slow To Recover Post-Pandemic

Storing Your Banks With Ease And Confidence

Virus Risk Mitigation In The Development Of Biological Medicinal Products: A Global Regulatory Perspective Vaccine Cell Bank And Virus Seed Characterization

How To Improve API Solubility By Salt And Cocrystal Formation

Behind the Scenes: Downstream Hardware Equipment Manufacturing In Umeå

Protecting Biopharma Manufacturing Supply Chains

Levers For Streamlining And Optimizing The Biosimilar Process

Facing NASH Therapeutic Skepticism With 89bio's Rohan Palekar

Cell And Gene Therapy Innovations

Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

Select Your Best Downstream Process Intensification Strategy

Streamline Production With A Final Filling Single-Use Set

MilliporeSigma Bio-Expo Live February 2025: Upstream Bioprocessing

Fill And Finish: Your Final Step Is Our First Priority

The Necessity Of Potency Assay Matrices For Complex Proteins

Building A Comprehensive Control Strategy For Biosimilar Analytics

Multi-Specific Antibody Development: What Challenges The Need For Speed?

Custom GMP-Grade Oligos

How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad

Exploring Dendritic Cell Therapy for Solid Tumors with Diakonos Oncology's Jay Hartenbach

Cell & Gene: The Podcast Presents: Better Biopharma's Editors' Roundtable — A Midyear Look at the 2026 Life Sciences Industry

Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers

Reimagining In Vivo Gene Editing Through Base Editing and Targeted Delivery with Beam Therapeutics' Gopi Shanker, Ph.D.

Advancing CAR T for Drug-Free Remission in Autoimmune Disease with Kyverna Therapeutics' Dr. Naji Gehchan

The Future of In Vivo Gene Editing and Clinical Translation with Precision Biosciences' Cassie Gorsuch, Ph.D.

Redefining CAR-T Timing and Patient Access with Allogene Therapeutics' Dr. Zachary Roberts

Building Integrated cGMP Systems for Autologous Cell Therapies with MassGen's Tatyana Matveeva, Ph.D.

Rewriting Disease Biology Through LSD1 Inhibition with Oryzon's Carlos Buesa, Ph.D.

Advancing Early Detection in Rare Cancers with Catriona Jamieson, M.D., Ph.D.

Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka

Modulating Multispecific Manufacturability With AP Biosciences' JJ You, Ph.D.

The Facility Master Planning Playbook With Herman Bozenhardt

Cell Therapy Without The Cells: Building A Therapeutic Secretome With Noveome Biotherapeutics' Larry Brown, Sc.D.

The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry

Validation Challenges Facing Advanced Single-Use Technologies

Aligning Upstream And Downstream Development (Part 2)

Aligning Upstream And Downstream Development (Part 1)

Reprogramming T Cells And Reducing Manufacturing Costs With RegCell's Michael McCullar, Ph.D.

Scaling Regenerative Medicine Production With PolarityBio's Nikolai Sopko, MD, Ph.D.

Pursuing Quality While Maintaining Process Control With Richard Moroney, Ph.D.

Unlocking The Therapeutic Power Of Fibroblasts With Pete O'Heeron And Hamid Khoja, Ph.D.

Supporting The Bioprocessing Workforce In The AI Era With Sanofi's Eric Doerr